| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 23 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 23 |
| 2 | TACROLIMUS OINTMENT 0.1% | 23 |
| 3 | MYCOPHENOLATE MOFETIL | 18 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 18 |
| 5 | PREDNISONE | 15 |
| 6 | FLUCONAZOLE | 7 |
| 7 | PREDNISOLONE | 6 |
| 8 | PREDNISOLONE ORAL | 6 |
| 9 | PREDNISOLONE ORAL SOLUTION | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHYLDOPA | 4 | 0.0008 |
| 1 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 2 | PRAZOSIN | 4 | 0.0006 |
| 3 | ZANUBRUTINIB | 2 | 0.0004 |
| 4 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 5 | ENTECAVIR | 4 | 0.0003 |
| 6 | BASILIXIMAB | 4 | 0.0003 |
| 7 | CALCITRIOL CAPSULES 0.25 MCG | 4 | 0.0002 |
| 8 | TACROLIMUS OINTMENT 0.1% | 23 | 0.0002 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 23 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Vitamin D3 Analog [EPC] | 4 | 0.0002 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 5 | 0.0001 |
| 5 | Insulin [EPC] | 4 | 0.0001 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 5 | 0.0001 |
| 9 | Azole Antifungal [EPC] | 7 | 0.0000 |